Molecular Mechanisms in the Pathogenesis and Treatment of Acute Ischemic Stroke

REFERENCES

• Ovbiagele B, Kidwell C, Starkman S, Saver J L. Neuroprotective agents for the treatment of acute ischemic stroke. Curr Neurol Neurosci Rep 2003; 3: 9–20, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Muir K W, Lees K R. Excitatory amino acid antagonists for acute stroke. Cochrane Stroke Group, OxfordUK 2003
   Google Scholar
• Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?. Lancet 2002; 1: 383–386, [CSA], [CROSSREF]
   Google Scholar
• Limpar P, Hanley D. General care in the acute phase. See also Bath P Management of blood pressure in acute stroke. Acute Stroke Treatment 2nd ed. 2003; 113: 122
   Google Scholar
• Clarke R L, Clifton E. The treatment of cerebrovascular thromboses and embolism with fibrinolytic agents. Am J Cardiol 1960; 6: 546–551, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Herndon R M, Meyer J S, Johnson J F. Fibrinolysin therapy in thrombotic diseases of the nervous system. J Mich State Med Soc 1960; 59: 1684–1692, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Meyer J S, Gilroy J, Barnhart M I, Johnson J F. Anticoagulants plus streptokinase therapy in progressive stroke. J Am Med Assoc 1964; 189: 373
   PubMed Web of Science ®Google Scholar
• J S, Gilroy J, Barnhart M I, Johnson J F. Therapeutic thrombolysis in cerebral thromboembolism. Neurology 1963; 13: 927–937, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fletcher A P, Alkjersig N, Lewis M, Tulevski V, et al. A pilot study of urokinase therapy in cerebral infarction. Stroke 1976; 7: 135–142, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Fears R. Biochemical pharmacology and therapeutic aspects of thrombolytic agents. Pharmacol Rev 1990; 42: 202–222
   Google Scholar
• Larcan A, Laprevote-Heully M C, Lambert H, et al. Indications des thrombolytiques au cours des accidents vasculaires cerebraux thrombosants traites par ailleurs par O.H.B. (2ATA). Therapie 1977; 32: 259–270, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Topol E J. Acute myocardial infarction: Treatment with thrombolytic therapy. Cardiol Clin 1989; 7(4)827–836, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Stark K S, Green C E. Intervention in acute myocardial infarction. Radiol Clin North Am 1989; 27(6)1205–1215, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Update: Thrombolysis. J Cardiovasc Nurs 1989; 4(1)1–89, v–vi
   Google Scholar
• Trask J L, Trask I NW, II, Cushing W J, et al. Intravenous streptokinase therapy for myocardial infarction in a community hospital: Effect on ventricular function and mortality. J S C Med Assoc 1989; 85(11)503, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Green J A. Risks versus benefits: The alteplase experience. Am J Hosp Pharm 1989; 46(11)S15–S19, Suppl 2[PUBMED], [INFOTRIEVE]
   Google Scholar
• Kanamasa K, Watanabe I, Cercek B, et al. Selective decrease in lysis of old thrombi after rapid administration of tissue-type plasminogen activator. J Am Coll Cardiol 1989; 14(5)1359–1364, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Packer C, Stevens A, Cook A, et al. Diffusion of thrombolysis for acute myocardial infarction from 1981 to 2000 in England: Trend analysis and comparison with need. Int J Technol Assess Health Care 2004; 20(4)531, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Castaigne A, Duval-Moulin A M, Dubois-Rande J L, et al. Physiopathologic basis of the use of thrombolytic agents during the acute phase of myocardial infarction. Arch Mal Coeur Vaiss 1989; 3: 15–30
   Google Scholar
• Topol E J, Ellis S G, Califf R M, et al. Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. J Am Coll Cardiol 1989; 14(4)877–884, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Reperfusion injury after thrombolytic for acute myocardial infarction. Lancet 1989; 2(8664)655–657, [CROSSREF]
   Google Scholar
• Cassidy D B, Smalling R W. Acute MI: Role of thrombolysis and intervention. Crit Care Clin. 1989; 5(3)435–453, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Tate D A, Dehmer G J. New challenges for thrombolytic therapy. Ann Int Med. 1989; 110(12)953–955, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Ouriel K, Kaul A F, Leonard M C. Clinical and economic outcomes in thrombolytic treatment of peripheral arteriocclusive disease and deep venous thrombosis. J Vasc Surg. 2004; 40(5)971–977, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Benedek I, Hintea T, Benedek I. Intra-arterial segmental thrombolysis in patients with arterial embolism of cardiac origin. Rom J Intern Med 1999; 37(1)15–23, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Del Zoppo G J, Zeumer H, Harker L A. Thrombolytic therapy in stroke: Possibilities and hazards. Stroke 1986; 17(4)595–607, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sloan M A. Thrombolysis and stroke. Past and future. Arch Neurol. 1987; 44(7)748–768, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Poeck K. Intraarterial thrombolytic therapy in acute stroke. Acta Neurol Belg 1988; 88(1)35–45, [PUBMED], [INFOTRIEVE]
   Google Scholar
• del Zoppo G, Poeck K, Pessin M S, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32: 78–86, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Clark W. Reperfusion injury in stroke. Emedicine 2001; 2: 15–18
   Google Scholar
• Chen S D, Lee J M, Yang D I, Nassief A, Hsu C Y. Combination therapy for ischemic stroke: Potential of neuroprotectants plus thrombolytics. Am J Cardiovasc Drugs. 2002; 2(5)303–313, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Dawson V L, Dawson T M. Intracellular signaling: Mediators and protective responses. Stroke Pathophysiology, Diagnosis, and Management, 4th ed. Churchill Livingstone, Philadelphia, PA 2004; 895–902
   Google Scholar
• Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 1997; 20(3)132–139, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ikonomidou C, Stefovsaka V, Turski L. Neuronal death enhanced by N-methyl-D-aspartate receptor antagonists in injured brain. Proc Natl Acad Sci USA 2000; 97: 12885–12890, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McCulloch J. Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man. J Clin Pharmacol 1992; 34: 106–14
   Google Scholar
• Grotta J C. Acute stroke therapy at the millennium: Consummating the marriage between the laboratory and the bedside. Stroke 1999; 30: 1722–1728, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Clausen T, Bullock R. Medical treatment and neuroprotection in traumatic brain injury. Curr Pharm Des 2001; 7: 1517–1532, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kagiyama T, Glushavok A V, Sumners C, et al. Neuroprotective Action of halogenated derivatives of L-phenylalanine. Stroke 2004; 35: 1192–1196, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Koh J Y, Goldberg M P, Hartley D M, et al. Non-NMDA receptor-mediated neurotoxicity in cortical culture. J Neurosci. 1990; 10: 693–705, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Horn J, Limburg M. Calcium antagonists for ischemic stroke: A systematic review. Stroke. 2001; 32: 570–576, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• DeGraba T J, Ostrow P T, Grotta J C. Threshold of calcium disturbance after focal cerebral ischemia in rats. Implications of the window of therapeutic opportunity. Stroke 1993; 24(8)1212–1216, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Horn J, et al. Nimodipine in animal model experiments of focal cerebral ischemia. Stroke. 2001; 32: 2433, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jensen B S. BMS-204352: A potassium channel opener developed for the treatment of stroke. CNS Drug Rev 2002; 8(4)353–360, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Bozik M, Hommel M, Grotta J, et al. Efficacy and safety of Maxi-PostTM in patients with acute stroke [abstract]. J Neurol Sci 2001; 187: s252
   Google Scholar
• Labiche L A, Grotta J C. Pharmacologic modification of acute cerebral ischemia. Stroke: Pathogenesis, Diagnosis, and Management. Churchill Livingtone, Philadelphia, PA 2004; 1025–1058
   Google Scholar
• Saver J L, Kidwell C, Eckstein M, Starkman S. FAST-MAG Pilot Trial Investigators. Prehospital neuroprotective therapy for acute stroke: Results of the field administration of stroke therapy-magnesium (FAST-MAG) pilot trial. Stroke 2004; 35(5)e106–e108, Epub 2004 Mar 11[PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zukin R S, Jover T, Yokota H, et al. Molecular and cellular mechanisms of ischemia-induced neuronal death. Stroke: Pathogenesis, Diagnosis, and Management. Churchill Livingtone, Philadelphia, PA 2004; 829–854
   Google Scholar
• Iadecola C. The role of NO in cerebrovascular regulation and stroke. The Haemodynamic Effects of Nitric Oxide, R T Mathie, T M Griffic. Imperial College Press, London 1999; 202
   Google Scholar
• Sobey C G, Faraci F M, Heistad D D. Vascular biology and therosclerosis of cerebral arteries. Stroke: Pathogenesis, Diagnosis, and Management. Churchill Livingtone, Philadelphia, PA 2004; 763–774
   Google Scholar
• Iadecola C, Cho S, Feurstein G Z, et al. Cerebral ischemia and inflammation. Stroke: Pathogenesis, Diagnosis, and Management. Churchill Livingtone, Philadelphia, PA 2004; 883–894
   Google Scholar
• Gertz K, Laufs U, Lindauer D VM, et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 2003; 34: 551–557, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sironi L, Cimino M, Geurrini U, et al. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damange. Arterioscler Throm Vasc Biol. 2003; 23: 322–327, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dirnagl U, Iadecola C, Moskowitz M A. Pathology of ischemic stroke: An integrated view. Trends Neurosci 1999; 22: 391–397, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kitagawa K, Matsumoto M, Mabuchi T, et al. Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia. J Cereb Blood Flow Metab 1998; 18(12)1336–1345, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Prestigiacomo C J, Kim S C, Connolly E S, Jr, et al. CD18-mediated neutrophil recruitment contributes to the pathogenesis o f reperfused but not nonreperfused stroke. Stroke 1999; 30: 1110–1117, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Soriano S G, Coxon A, Wang Y F, et al. Mice deficient in Mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke 1999; 30: 134–139, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Connolly E S, Jr, Winfree C J, Springer T A, et al. Cerebral protection in homozygous null F-1 mice after middle cerebral artery occlusion: Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 1996; 97: 209–216, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Connolly E S, Jr, Winfree C J, Prestigiacomo C J, et al. Exacerbation of cerebral injury in mice that express the P-selectin gene: Identification of P-selectin blockade as a new target for the treatment of stroke. Circ Res 1997; 81: 304–310, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Clark W M, Madden K P, Rothlein R, et al. Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 1991; 22: 877–883, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Clark W M, Madden K P, Rothlein R, et al. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J Neurosurg 1991; 75: 623–627, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Onodera H, Shiga Y, et al. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 1994; 656: 344–352, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bowes M P, Zivin J A, Rothlein R. Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model. Exp Neurol 1993; 119: 215–219, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chen H, Chopp M, Zhang R L, et al. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann Neurol 1994; 35: 458–463, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chopp M, Zhang R L, Jiang N. The role of adhesion molecules in reducing cerebral ischemic cell damage. Adv Neurol 1996; 71: 315–326, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Chopp M, Zhang R L, Jiang N, Zhang Z G. Anti-adhesion molecule antibodies reduce ischemic cell damage after transient MCAO in the rat. J Cereb Blood Flow Metab 1995; 15: S57, (suppl 1)
   Google Scholar
• Zhang R L, Chopp M, Jiang N, et al. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 1995; 26: 1438–1442, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Chopp M, Li Y, Jiang N, Zhang R L, et al. Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain. J Cereb Blood Flow Metab 1996; 16: 578–584, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Relton J K, Sloan K E, Frew E M, et al. Inhibition of α4 integrin protects against transient focal cerebral ischemia in normotensive and hypertensive rats. Stroke 2001; 32: 199–205, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Becker K, Kindrick D, Relton J, et al. Antibody to the α4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 2001; 32: 206–211, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Frijns C J, Kappelle L J. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 2002; 33: 2115, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sherman D G. The Enlimomab Acute Stroke Trial: Final results (abstract and presentation) in 49th annual meeting of the American Academy of Neurology. Neurology 1997; 48: A270
   Google Scholar
• Furuya K, Takeda H, Azhar S. Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of Enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody. Stroke 2001; 32: 2665, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Benchoua A, Guegan C, Couriaud C, et al. Specific caspase pathways are activated in the two stages of cerebral infarction. J Neurosci 2001; 21(18)7127–7134, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Zheng Z, Zhao H, Steinberg G K, et al. Cellular and molecular events underlying ischemia-induced neuronal apoptosis. Drug News Perspect 2003; 16(8)497–503, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Phan T G, Wright P M, Markus R, et al. Salvaging the ischaemic penumbra: More than just reperfusion?. Clin Exp Pharmacol Physiol 2002; 29(1–2)1–10, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Dalkara T, Moskowitz M M. Apoptosis in cerebral ischemia. Stroke: Pathophysiology, Diagnosis, and Management. Churchhill Livingstone, Philadelphia, PA 2004; 855–866
   Google Scholar
• Onteniente B, Couriaud C, Braudeau J, et al. The mechanisms of cell death in focal cerebral ischemia highlight neuroprotective perspectives by anti-caspase therapy. Biochem Pharmacol 2003; 66(8)1643–1649, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Rabuffetti M, Sciorati C, Tarozzo G, et al. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J Neurosci 2000; 20(12)4398–4404, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Labiche L A, Grotta J C. Clinical trials for cytoprotection in stroke. NeuroRx 2004; 1: 46–70, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Love S, Barber R, Wilcock G K. Neuronal death in brain infarcts in man. Neuropathol Appl Neurobiol 2000; 26(1)55–66, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jones P A, May G R, Mclucki J A, et al. Apoptosis is not an invariable component of in vitro models of cortical cerebral ischaemia. Cell Res. 2004; 14(3)241–250, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Moroni F, Meli E, Peruginelli F, et al. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ 2001; 8(9)921–932, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   Google Scholar
• Liao S L, Chen W Y, Raung S L, et al. Neuroprotection of naloxone against ischemic injury in rats: Role of mu receptor antagonism. Neurosci Lett 2003; 345(3)169–172, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Goyagi T, Toung T JK, Kirsch J R, Traystman R J, Koehler R C, Hurn P D, Bhardwaj A. Neuroprotective κ -opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats. Stroke 2003; 34: 1533–1538, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Chen T Y, Goyagi T, Toung T JK, Kirsch J R, Hurn P D, Koehler R C, Bhardwaj A. Prolonged opportunity for ischemic neuroprotection with selective κ -opioid receptor agonist in rats. Stroke. 2004; 35: 1180–1185, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Adams H P, Jr, Olinger C P, Barsan W G, et al. A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia. Stroke 1986; 17(3)404–409, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Federico F, Lucivero V, Lamberti P, et al. A double blind randomized pilot trial of naloxone in the treatment of acute ischemic stroke. Ital J Neurol Sci 1991; 12(6)557–563, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Olinger C P, Adams H P, Jr, Brott T G, et al. High-dose intravenous naloxone for the treatment of acute ischemic stroke. Stroke 1990; 21(5)721–725, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Maier C M, Ahern K B, Cheng M D, et al. Optimal depth and duration of mild hypothermia in a focal model of transient cerebral ischemia: Effects of neurological outcome, infarct size, apoptosis, and inflammation. Stroke 1998; 29: 2191
   Google Scholar
• Corbett D, Hamilton M, Colburne F. Persistent neuroprotection with prolonged postischemic hypothermia in adult rats subjected to transient middle cerebral artery occlusion. Exp Neurol 2000; 163: 200, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kawai N, Okauchi M, Morisaki K, et al. Effects of delayed intraischemic and postischemic hypothermia on a focal model of transient cerebral ischemia in rats. Stroke 2000; 31: 1982, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Holzer M. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. Hypothermia after Cardiac Arrest Study Group. N Engl J Med 2002; 346(8)549–556, [CSA], [CROSSREF]
   Google Scholar
• Zausinger S, Scholler K, Plesnila N, et al. Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats. Stroke 2003; 34(9)2246–2251, Epub 2003 Jul 31[PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Han H S, Karabiyikoglu M, Kelly S, Sobel R A, Yenari M A. Mild hypothermia inhibits nuclear factor-κ B translocation in experimental stroke. J Cereb Blood Flow Metab. 2003; 23: 589–598, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Centers f or. Disease Control and Prevention. Awareness of stroke warning signs—17 States and the U.S. Virgin Islands, 2001. Morbid Mortal Wkly Rep 2004; 17: 359–362, [CSA]
   Google Scholar
• Purves D, Augustine G J, Fitzpatrick D, et al. Neuroscience, 2nd ed. Sinauer, Sunderland, MA 2001
   Google Scholar